Microsoft word - ccmm product spec.doc

THE CLINICAL CHEMISTRY MARKET MONITOR™
The Clinical Chemistry MARKET MONITOR™ is a tracking study designed to monitor (1) the growth rate of the clinical
chemistry market in terms of the number of tests performed per year and (2) the sales performance of those
manufacturers providing clinical chemistry instruments and reagents to this market. Published annually, The Clinical
Chemistry MARKET MONITOR™ addresses testing for selected analytes in two primary market segments including
(1) hospitals and (2) commercial laboratories and is comprehensive in terms of the scope of test categories reported.
The test categories addressed in this report include (1) general chemistry, (2) immunochemistry, (3) therapeutic drug
monitoring, (4) drugs of abuse/toxicology, (5) cardiac, and (6) specific proteins. A wide range of secondary data
classification schemes are also presented in this report for those participating laboratories including (1) general
chemistry test volume, (2) immunochemistry menu width and test volume, and (3) the date of the most recent
instrument acquisition.
Contents:
Market Size
Segmentation
Hospital Labs
Average number of results per laboratory Commercial Labs
Examples
Of Custom
Segmentation
Categories
Instrumentation brand/model
Number of accounts in the market for new Competitive Performance
Data Collection Methodology:
Number of results generated on each The majority of MARKET MONITOR™ data is gathered via a highly structured mail survey. This data col ection Volume Share
technique has been selected for several reasons. • The self-administered form al ows the respondent to complete the interview at a convenient time, thus Client Base
Change in the number of clients from the • Consultation with records or col eagues is also permitted so that questions requiring data beyond the immediate recal of the respondent can be col ected. Revenue Share Average reagent price per test
• The mail survey technique provides a cost effective To provide a sensitive measure of change, the same institutions are sampled each cycle. A telephone survey is employed as a fol ow-up to maintain the integrity of the database and to complete surveys for multi-departmental laboratories. Analytes Included In The Study:
General Chemistry Section
The General Chemistry Section is instrument oriented and focuses on instrument issues only. For reagent aspects of general chemistry, see the General Chemistry Constituent Fol ow-Up Section below for a detailed list of analytes included. Data for the General Chemistry Section is collected in January of each year.
Immunochemistry Section
Data for the Immunochemistry Section is collected in January of each year.
General Chemistry Constituent Follow-Up
Transferase; Aspartate Amino (ALT) (SGOT) Data for the General Chemistry Constituent Follow-Up is collected in July of each year.
TDM Follow-Up
Drugs Of Abuse/Toxicology Follow-Up
Data for the TDM Follow-Up and Drugs Of Abuse/Toxicology Follow-Up is collected in July of each year.
Specific Proteins Follow-Up
Data for the Specific Proteins Follow-Up is collected in October of each year.
Additional Follow-Up Sections:
Mid Year Instrument Placement And Acquisition Intention
• Projects the number of general chemistry or immunochemistry analyzers placed in first half of year • Details the intention to acquire a general chemistry or immunochemistry analyzer in the next 12 months • Includes details of brands under consideration for acquisition Data for the Mid Year Instrument Placement And Acquisition Intention is collected in July of each year.
Cardiac Follow-Up
In addition to the quantitative information, the Cardiac Fol ow-Up offers insight into the attitudes of laboratorians with regard to short-term changes in cardiac testing. Based on a series of focus groups this fol ow-up report investigates such issues as (1) the acceptance of point-of-care testing, (2) the factors influencing cardiac testing product selection, and (3) the possible changes in testing protocol that could influence test volume in the future. Data for the Cardiac Follow-Up is collected in December of each year.
Pricing:
Market Segmentation:
2007 Report (19th Cycle)
With approximately 1,400 laboratories participating in this data col ection effort, both the hospital and non-hospital Routine Chemistry Section*
commercial laboratory market segments are wel Includes:
General Chemistry**
represented in this report. It should be noted that the Immunochemistry***
physicians’ office laboratories as wel as group practice Drugs Of Abuse/Toxicology Follow-Up
facilities are not included in The Clinical Chemistry
Cardiac Follow-Up
This database is large enough to provide statistical y Specific Proteins Follow-Up
sensitive reporting for five hospital categories and four General Chemistry Constituent Follow-Up
non-hospital commercial laboratory categories segmented by size. These primary market segments include the Total Report (All Above Sections Included)
$168,000
Includes General Chemistry and Immunochemistry Sections, Hospitals By Bed Size
TDM Fol ow-Up, General Chemistry and Immunochemistry Acquisition Intention For 2007, and Mid Year Instrument
** Includes General Chemistry Section, TDM Fol ow-Up, General
Chemistry Pricing Report, Acquisition Intention For 2005 (General Chemistry Section Only), and Mid Year Instrument Non-Hospital Commercial
Placement And Acquisition Intention (General Chemistry Laboratories By Annual Test Volume

*** Includes
Immunochemistry Pricing Report, Immunoassay Utilization Summary, Acquisition Intention For 2005 (Immunochemistry Section Only), and Mid Year Instrument Placement And Acquisition Intention (Immunochemistry Section Only). The study sample has been selected to provide representation of al regions within the domestic United States market. Hospital control has also been considered and the number of respondents in each control group is approximately proportional to that of the universe. About Information Dynamics
Information Dynamics is a marketing information development company serving manufacturers within the
healthcare device and diagnostic markets. In business for over 25 years, Information Dynamics has been the
major source of tracking data for the clinical diagnostics industry for more than a decade and has conducted
over 1,000 studies regarding behaviors and attitudes of clinical laboratorians.
For more information, please visit our website.
w w w . i n f o r m a t i o n d y n a m i c s . n e t
Other MARKET MONITOR™ Reports From Information Dynamics
The Coagulation
The Infectious Disease
MARKET MONITOR™
MARKET MONITOR™
Focused upon the coagulation market. Primary issues
Focused upon the automated and manual kit
addressed in this report include (1) size of the market
segments of the infectious disease testing market.
and (2) performance of manufacturers providing the
Primary issues addressed in this report include (1)
products used for coagulation testing. Published
the size of the market and (2) the performance of
annually, The Coagulation MARKET MONITOR™
manufacturers providing the products used to
provides information from (1) hospital laboratories and
perform these tests. Published annually, The
(2) commercial laboratories. Point-of-care testing
Infectious Disease MARKET MONITOR™ addresses
within the hospital segment for selected coagulation
testing for selected analytes in four primary market
tests is also addressed in this annual tracking study.
segments including (1) hospitals, (2) commercial
laboratories, (3) public health laboratories, and (4)
blood donor centers.
The Hematology
The Laboratory Automation
MARKET MONITOR™
MARKET DEVELOPMENT MONITOR™
Focused upon the hematology market. Primary issues
Created to aid those market planners interested in
addressed in this report include (1) size of the market
strengthening their firm’s position while accelerating
and (2) performance of manufacturers providing the
the growth of the automation segment of the clinical
products used for hematology testing. Published
laboratory. Although there are many automation
annually, The Hematology MARKET MONITOR™
issues at work in the laboratory, the focus of this
provides information from (1) hospital laboratories and
study is four topics, which appear to be of leading
(2) commercial laboratories. Point-of-care testing
importance in today’s market. These issues include
within the hospital segment for selected hematology
(1) pre-analytical automation, (2) post-analytical
tests is also addressed in this tracking study.
automation, (3) automated hematology, and (4) auto-
verification.
The Hospital Decentralized Testing
The Large Group Practice Laboratory
MARKET MONITOR™
MARKET MONITOR™
Focused upon hospital based testing performed
Focused upon the laboratory market within large
outside of the laboratory at the unit level such as in
group practices with six or more physicians. Primary
the Emergency Department or operating room.
issues addressed in this report include (1) market
Primary issues addressed in this report include (1) the
size and (2) manufacturer performance. A group
number of facilities that offer near patient testing for
practice laboratory is defined as a facility that
selected test groups, (2) the number of tests
employs either a general chemistry, immunoassay or
performed, and (3) the type of products used to
hematology analyzer within the practice facility.
perform these tests.
The Sales Effort
MARKET MONITOR™
Developed to track the perceived sales effort of each
a marketing information development company of the leading manufacturers from the customers’
point of view. To aid in the sales management
planning process, this study addresses issues central
to sales deployment for those manufacturers
interested in the general chemistry, immunoassay, and
hematology segments of the clinical laboratory
market.
w w w . i n f o r m a t i o n d y n a m i c s . n e t

Source: http://www.informationdynamics.net/PDF/CCMM2007.pdf